Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.49% | 176.12 | 0.7% | $1154.91m | |
| LLY | Eli Lilly & Co. | -0.17% | 368.68 | 1.1% | $1075.50m | |
| MRK | Merck & Co., Inc. | -0.98% | 108.93 | 0.7% | $992.38m | |
| PFE | Pfizer Inc. | -2.01% | 49.71 | 0.9% | $934.38m | |
| ABBV | AbbVie, Inc. | -0.11% | 163.76 | 1.9% | $884.04m | |
| BMY | Bristol-Myers Squibb Co. | -0.98% | 79.91 | 1.1% | $741.36m | |
| AZN | AstraZeneca Plc | 0.21% | 68.56 | 1.0% | $355.43m | |
| HZNP | Horizon Therapeutics Plc | -1.66% | 96.85 | 5.4% | $295.13m | |
| GSK | GSK Plc | 7.85% | 37.92 | 0.3% | $247.06m | |
| IDXX | IDEXX Laboratories, Inc. | -1.64% | 415.39 | 3.9% | $191.92m | |
| NVS | Novartis AG | -0.25% | 90.73 | 0.2% | $185.59m | |
| CTLT | Catalent, Inc. | -5.00% | 48.23 | 1.9% | $175.42m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -2.90% | 219.64 | 8.0% | $156.22m | |
| NVO | Novo Nordisk A/S | -1.03% | 125.77 | 0.1% | $154.68m | |
| SNY | Sanofi | 8.06% | 48.55 | 0.2% | $133.18m |
Company Profile
Cybin, Inc. is an ethical biopharmaceutical company engaged in the development of therapeutics for patients to address a multitude of mental health issues. It is focused on progressing psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment regimens for mental health disorders. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.